Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II trial of Xiaoer Ma-Long-Zhi-Ke-Ping-Chuan Granules in children with cough variant asthma
ChiCTR2000032744Phase 2Recruiting
- Sponsor
- Shanghai Municipal Hospital of Traditional Chinese Medicine
- Start
- Nov 2018
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of Xiaoer Ma-Long-Zhi-Ke-Ping-Chuan Granules in cough variant asthma (CVA) (3 arms), sponsored by Shanghai Municipal Hospital of Traditional Chinese Medicine. Primary endpoints: Cough severity (day and night) score, Onset time and efficiency of cough improvement and 1 more. Started Nov 2018; status: recruiting.
02
Drugs
Xiaoer Ma-Long-Zhi-Ke-Ping-Chuan Granules
03
Conditions
cough variant asthma (CVA)
Beyond the preview
Go deeper on ChiCTR2000032744.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000032744.